Skip to main content
Log in

Low LDL-C/HDL-C Ratio is Associated with Poor Clinical Outcome After Intracerebral Hemorrhage: A Retrospective Analysis of Multicenter, Prospective Cohort Data in China

  • Original work
  • Published:
Neurocritical Care Aims and scope Submit manuscript

An Invited Commentary to this article was published on 19 January 2024

Abstract

Background

The association between low-density lipoprotein cholesterol (LDL-C)/high-density lipoprotein cholesterol (HDL-C) ratio and the clinical outcomes of acute intracranial hemorrhage (ICH) remains unclear. In this study, we attempt to investigate whether low LDL-C/HDL-C ratio is associated with poor clinical outcomes in patients with ICH.

Methods

The database was collected from a multicenter, prospective, observational cohort study, conducted in 13 hospitals in Beijing from January 2014 to September 2016. A total of 1,964 patients with ICH were initially screened in our database. Next, we selected patients with admission serum lipid information for retrospective analysis. Patients were categorized into four groups based on LDL-C/HDL-C ratio quartiles. The main outcomes were 30-day and 90-day poor functional outcome, which is defined as modified Rankin Scale score of 3 to 6, and 90-day all-cause death. Logistic regression was used to assess the association between LDL-C/HDL-C ratio and 30-day or 90-day poor functional outcome. Kaplan–Meier survival analysis and Cox regression were used to assess the association between LDL-C/HDL-C ratio and 90-day all-cause death. Restricted cubic splines were used to explore the nonlinear association between LDL-C/HDL-C ratio and the outcome of patients with ICH.

Results

A total of 491 patients with spontaneous ICH were finally enrolled in our study. The mean age was 57.6 years old, and 72.1% (357/491) were men. After adjustment for confounders, patients in the lowest LDL-C/HDL-C quartile (< 1.74) had a significantly higher risk of 30-day and 90-day poor functional outcome compared with those in the highest quartile (> 3.16; 30-day: adjusted odds ratio 3.61, 95% confidence interval 1.68–7.72; 90-day: adjusted odds ratio 2.82, 95% confidence interval 1.33–5.95). Restricted cubic splines depicted a nonlinear association between LDL-C/HDL-C ratio and 90-day poor functional outcomes, indicating LDL-C/HDL-C ratio of 3.1–3.5 was correlated with better 90-day functional outcome. However, no significant correlation was found between low LDL-C/HDL-C ratio and 90-day all-cause death.

Conclusions

Lower LDL-C/HDL-C ratio (< 1.74) is independently associated with an increased risk of poor functional outcome in patients with ICH. In the population of patients whom we studied, there is a nonlinear association between LDL-C/HDL-C ratio and 90-day poor functional outcome, and patients with an LDL-C/HDL-C ratio of 3.1 to 3.5 tend to have the lowest risk of 90-day poor functional outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135:759–71.

    Article  PubMed  Google Scholar 

  2. Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820.

    Article  CAS  Google Scholar 

  3. Cannon CP. Low-density lipoprotein cholesterol: lower is totally better. J Am Coll Cardiol. 2020;75:2119–21.

    Article  PubMed  Google Scholar 

  4. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–88.

    Article  PubMed  Google Scholar 

  5. Katakami N, Kaneto H, Osonoi T, Saitou M, Takahara M, Sakamoto F, et al. Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients. Atherosclerosis. 2011;214:442–7.

    Article  CAS  PubMed  Google Scholar 

  6. Zhong Z, Hou J, Zhang Q, Zhong W, Li B, Li C, et al. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation. Lipids Health Dis. 2019;18:40.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gao P, Wen X, Ou Q, Zhang J. Which one of LDL-C /HDL-C ratio and non-HDL-C can better predict the severity of coronary artery disease in STEMI patients. BMC Cardiovasc Disord. 2022;22:318.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kunutsor SK, Zaccardi F, Karppi J, Kurl S, Laukkanen JA. Is high serum LDL/HDL cholesterol ratio an emerging risk factor for sudden cardiac death? Findings from the KIHD study. J Atheroscler Thromb. 2017;24:600–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rodriguez-Luna D, Rubiera M, Ribo M, Coscojuela P, Pagola J, Piñeiro S, et al. Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage. Stroke. 2011;42:2447–52.

    Article  CAS  PubMed  Google Scholar 

  10. Ramírez-Moreno JM, Casado-Naranjo I, Portilla JC, Calle ML, Tena D, Falcón A, et al. Serum cholesterol LDL and 90-day mortality in patients with intracerebral hemorrhage. Stroke. 2009;40:1917–20.

    Article  PubMed  Google Scholar 

  11. Elkhatib THM, Shehta N, Bessar AA. Hematoma expansion predictors: laboratory and radiological risk factors in patients with acute intracerebral hemorrhage: a prospective observational study. J Stroke Cerebrovasc Dis. 2019;28:2177–86.

    Article  PubMed  Google Scholar 

  12. Wang Y, Wu J, Gu H, Yang K, Jiang R, Li Z, et al. Lower low-density lipoprotein cholesterol levels are associated with an increased risk of hematoma expansion and ensuing mortality in acute ICH patients. Neurol Sci. 2022;43:3121–9.

    Article  PubMed  Google Scholar 

  13. Yuan S, Huang X, Ma W, Yang R, Xu F, Han D, et al. Associations of HDL-C/LDL-C with myocardial infarction, all-cause mortality, haemorrhagic stroke and ischaemic stroke: A longitudinal study based on 384 093 participants from the UK Biobank. Stroke Vasc Neurol. 2022;svn-2022–001668.

  14. You S, Zhong C, Xu J, Han Q, Zhang X, Liu H, et al. LDL-C/HDL-C ratio and risk of all-cause mortality in patients with intracerebral hemorrhage. Neurol Res. 2016;38:903–8.

    Article  CAS  PubMed  Google Scholar 

  15. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27.

  16. Spence JD. Statins do not cause intracerebral hemorrhage. Neurology. 2012;79:1076–7.

    Article  PubMed  Google Scholar 

  17. Sanz-Cuesta BE, Saver JL. Lipid-lowering therapy and hemorrhagic stroke risk: comparative meta-analysis of statins and PCSK9 inhibitors. Stroke. 2021;52:3142–50.

    Article  CAS  PubMed  Google Scholar 

  18. Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lavallée PC, et al. Intracranial hemorrhage in the TST trial. Stroke. 2022;53:457–62.

    Article  PubMed  Google Scholar 

  19. Gu X, Li Y, Chen S, Yang X, Liu F, Li Y, et al. Association of lipids with ischemic and hemorrhagic stroke: a prospective cohort study among 267 500 Chinese. Stroke. 2019;50:3376–84.

    Article  PubMed  Google Scholar 

  20. Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke. 2007;38:3198–204.

    Article  CAS  PubMed  Google Scholar 

  21. Wang X, Li S, Bai Y, Fan X, Sun K, Wang J, et al. Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage. J Lipid Res. 2011;52:1747–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. O’Donnell MJ, McQueen M, Sniderman A, Pare G, Wang X, Hankey GJ, et al. Association of lipids, lipoproteins, and apolipoproteins with stroke subtypes in an international case control study (INTERSTROKE). J Stroke. 2022;24:224–35.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38:2718–25.

    Article  PubMed  Google Scholar 

  24. Wang X, Dong Y, Qi X, Huang C, Hou L. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke. 2013;44:1833–9.

    Article  CAS  PubMed  Google Scholar 

  25. Ooneda G, Yoshida Y, Suzuki K, Shinkai H, Hori S, Kobori K, et al. Smooth muscle cells in the development of plasmatic arterionecrosis, arteriosclerosis, and arterial contraction. J Vasc Res. 1978;15:148–56.

    Article  CAS  Google Scholar 

  26. Konishi M, Iso H, Komachi Y, Iida M, Shimamoto T, Jacobs DR, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. Akita Pathol Study Stroke. 1993;24:954–64.

    Article  CAS  Google Scholar 

  27. Chui D, Marotta F, Rao M, Liu D, Zhang S, Ideo C. Cholesterol-rich LDL perfused at physiological LDL-cholesterol concentration induces platelet aggregation and PAF-acetylhydrolase activation. Biomed Pharmacother. 1991;45:37–42.

    Article  CAS  PubMed  Google Scholar 

  28. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.

    Article  CAS  PubMed  Google Scholar 

  29. Hankey GJ. Nutrition and the risk of stroke. Lancet Neurol. 2012;11:66–81.

    Article  CAS  PubMed  Google Scholar 

  30. Jayanama K, Theou O, Blodgett JM, Cahill L, Rockwood K. Frailty, nutrition-related parameters, and mortality across the adult age spectrum. BMC Med. 2018;16:188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The study was supported by National Natural Science Foundation of China (Grant No. 82371302), Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2019-I2M-5–029), National Key Research and Development Program of China (2018YFC1312200/ 2018YFC131224), Beijing Municipal Committee of Science and Technology (Z201100005620010), Beijing Natural Science Foundation (Z200016), Beijing key clinical specialty and Ministry of Science and Technology of the People’s Republic of China (National Key R&D Program of China, 2018YFC1705003). We thank all patients who participated in our study.

Author information

Authors and Affiliations

Authors

Contributions

LW analyzed, interpreted the data, and drafted the original manuscript. KK analyzed and interpreted the data. AW and XZ conducted the statistical analyses. WW designed the research. XZ designed the research, and handled the funding and supervision. The final manuscript was approved by all authors.

Corresponding author

Correspondence to Wenjuan Wang.

Ethics declarations

Conflict of Interest

The authors report no conflict of interest in this work.

Ethical approval/informed consent

This study protocol was reviewed and approved by the Institutional Review Board of Beijing Tiantan Hospital, Capital Medical University, approval number KY2014-023–02. Written informed consents were obtained from all participants or their legal relatives for the publication of any potentially identifiable data or images included in this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file 1 (DOCX 145 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, L., Wang, A., Kang, K. et al. Low LDL-C/HDL-C Ratio is Associated with Poor Clinical Outcome After Intracerebral Hemorrhage: A Retrospective Analysis of Multicenter, Prospective Cohort Data in China. Neurocrit Care (2023). https://doi.org/10.1007/s12028-023-01905-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12028-023-01905-z

Keywords

Navigation